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Objectives: Abdominal aortic aneurysm (AAA) sac shrinkage after endovascular aneurysm repair (EVAR) is considered to
be evidence of clinical success. Exclusion of the sac from systemic pressure is the likely cause of shrinkage. We report our
continuing clinical experience with the use of a permanently implantable, ultrasound-activated remote pressure trans-
ducer to measure intrasac pressure and its correlation with changes in sac diameter over time.
Methods: Over a 22-month period, 21 patients underwent EVAR of an infrarenal AAA with implantation of an ultrasound-
activated remote pressure transducer fixed to the outside of the stent-graft and exposed to the excluded aortic sac. Intrasac
pressures weremeasured directly with an intravascular catheter and by the remote sensor at the time of stent-graft deployment.
Follow-up sac pressures weremeasured by remote sensor and comparedwith systemic arterial pressure at every follow-up visit.
Mean follow-upwas 11.45.0months (range, 1 to26months). Twenty patients had follow-upof>6months.Meanpressure
index (MPI) was calculated as the ratio of mean sac pressure to mean systemic pressure.
Results: Pressures could be obtained at all visits in 15 of the 21 patients. Fourteen of these 15 patients had follow-up of at least
6 months. Aneurysm sac shrinkage of >5 mm was seen in seven (50%) of these 14 patients. No aneurysm enlargement was
observed in any patient. The MPI was significantly lower in patients with sac shrinkage at 6 months and at final follow-up.
Conclusions: Endovascular aneurysm repair results in marked reduction of sac pressure in most patients. Patients with
aneurysm shrinkage after EVAR have significantly lower MPI; however, the absence of sac shrinkage does not imply
persistent pressurization of the sac. Further clinical follow-up will delineate the role of long-term sac pressure monitoring
in surveillance after EVAR. (J Vasc Surg 2006;43:2-7.)Since the report of the first endovascular repair of an
abdominal aortic aneurysm (AAA) by Parodi et al in 1991,1
endovascular aneurysm repair (EVAR) has gained acceptance
for select patients as an alternative to traditional open sur-
gery.2,3 As with any form of vascular repair, however, long-
term durability is a concern.4 As a result, lifelong endograft
surveillance is considered necessary. Current surveillance pro-
tocols, including duplex, computed tomography (CT) scan,
and magnetic resonance angiography (MRA), are aimed at
identifying inadequate AAA exclusion, device migration,
and secondary markers of sac pressurization, specifically
AAA enlargement and endoleak. We report our continuing
experience with the first prospective analysis of a noninva-
sive long-term AAA sac pressure transducer to monitor
EVAR in humans and correlate it with changes in aneurysm
sac diameter.
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2METHODS
Since June 2003, 21 patients undergoing EVAR of an
infrarenal AAA were enrolled in this protocol, of which 19
patients received modular bifurcated devices, and two pa-
tients received aortouniiliac devices. Mean preoperative
aneurysm size was 6.2  1.0 cm (range, 4.7 to 8.2 cm).
Mean follow-up was 11.4  5.1 months (range, 1 to 22
months). This study was performed in conjunction with
our investigator-sponsored investigational device exemp-
tion (IDE) examining the use of the Talent endovascular
stent-graft (Medtronic AVE, Santa Rosa, Calif) in the
treatment of infrarenal AAA in the high-risk patient. The
expanded experimental protocol and informed consent
were approved by the United States Food and Drug Ad-
ministration and the Institutional Review Board of the
Mount Sinai School of Medicine. All subjects gave in-
formed consent.
Eligibility criteria. The Talent protocol is an investiga-
tor-sponsored IDE examining the use of the Talent-LPS
endovascular stent-graft in the repair of infrarenal AAAs in
high-risk patients. Patients must be deemed as high risk for
standard surgical therapy because of severe comorbid medical
illnesses. Anatomic criteria include a normal proximal neck of
at least 1.5 cm and a normal distal fixation zone of at least 1
cm, with access vessels of at least 8 mm in diameter.
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LPS endovascular stent-graft has been previously de-
scribed.5 This self-expanding endoprosthesis is composed
of woven polyester supported by nitinol Z-forms and a
longitudinal bar. The prosthesis comes in either an aortou-
niiliac or modular bifurcated configuration. Deployment is
by manual retraction of the outer sheath. The outer diam-
eter is 18F to 25F.
Pressure transducer description. The Remon Im-
pressure AAA Sac Pressure Transducer (Remon Medical,
Fig 1. The Remon Impressure AAA Sac Pressure Transducer
(Remon Medical, Cesaria, Israel).
Fig 2. Computed tomography scan demonstrates compression of
the pressure transducer between the limbs of the endograft (arrow
points to the artifact caused by the transducer).Caesaria, Israel) (Fig 1) has been previously described.6,7Briefly, the implant contains a piezoelectric membrane that
energizes a capacitor when actuated by ultrasound waves
from a hand-held probe. Once charged, a transducer within
the device measures ambient pressure and then generates
an ultrasound signal that is relayed to the hand-held probe.
The transducers were hand-sewn to the outside of the
stent-graft and then packaged in the delivery sheath. In
patients with an aortouniiliac device, the transducer was
sewn to the graft approximately 6 cm below the attachment
system. In patients with a bifurcated device, the device was
sewn to the contralateral limb just below where it exits the
main body gate and packaged in a 20F delivery sheath.
Deployment technique. The technique for stent-
graft deployment has been previously described.5 At the
time of stent-graft deployment, an intrasac 5F Berenstein
catheter (Boston Scientific, Natick, Mass) was placed in the
excluded aneurysm alongside the device. Blood pressures
were obtained from both arms intraoperatively and assessed
for concordance with the radial arterial catheter. Simulta-
neous catheter and ultrasound transducer pressures were
obtained in the operating room.
Follow-up. Follow-up consisted of a doctor’s office visit;
anteroposterior, lateral, and oblique abdominal radiographs;
and either three-phase contrast-enhancedCTA orMRA. This
was performed at 1, 6, and 12 months, and yearly thereafter.
To control for aortic tortuosity, the AAA diameter was mea-
sured in the axial sections as the perpendicular to the maximal
diameter when the aneurysm appeared elliptical. A shrinking
Table I. Stable vs shrinking aneurysms at 6 months
n* Median MPI† (range)
Stable 8 0.58 (0.17-1.2)
Shrinking 4 0.14 (0.04-0.18)
MPI, Mean pressure index.
*Two patients missed their 6-month follow-up window but came in later.
†P  .017.
Table II. Stable vs shrinking aneurysms at 12 months
n* Median MPI† (range)
Stable 6 0.53 (0.20-1.1)
Shrinking 6 0.24 (0.08-0.70)
MPI, Mean pressure index.
*Two patients missed their twelve month follow-up window but came in later.
†P  0.24.
Table III. Stable vs shrinking aneurysms at final follow-up
n Median MPI† (range)
Stable 7 0.54 (0.23-1.1)
Shrinking 7 0.22 (0.09-0.68)
MPI, Mean pressure index.
†P .048.aneurysm was defined as one with a decrease in the maximal
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with no change in maximal aortic diameter of 5 mm. In-
trasac pressures were obtained at each doctor’s visit. Systemic
pressure was obtained by using a pressure cuff applied to the
upper extremity. Patients were placed on a stretcher for a
minimum of 5 minutes before measurement, and multiple
pressure measurements were made at each visit.
Statistical analysis. The concordance between simulta-
neous pressure measurements was determined with the Pear-
son correlation. Normal distribution of MPI and changes in
sac diameter was not assumed. Values are presented as medi-
ans and 5th and 95th percentiles between parentheses when
not stated otherwise. The Mann-Whitney test was used for
unpaired comparisons. Significance was assumed at P .05.
RESULTS
Clinical success of endovascular repair. Primary
Change in AAA Diam
Fig 3. Scatterplot demonstrates the relationship betwee
aortic aneurysm (AAA) diameter at 6 months.
Change in AAA
Fig 4. Scatterplot demonstrates the relationship betwee
aortic aneurysm (AAA) diameter at 12 months.technical success was achieved in 20 (95%) of 21. One patientwas later diagnosed with a distal type I endoleak with outflow
via a patent lumbar artery at the 1-month follow-up visit. This
was successfully treated with an iliac extension cuff. This
patient’s residual type II endoleak has persisted. Three pa-
tients had type II endoleaks on their 1-month CT scans, two
froma lumbar artery andone fromapatent inferiormesenteric
artery and paired lumbar arteries. The lumbar endoleaks were
both closed as of the 6-month CT scan. The inferior mesen-
teric artery endoleakwas persistent on the 12-monthCT scan.
A final patient was diagnosed with a type II endoleak from
patent lumbar arteries onMRA at 9months.One patient died
of an unrelated cause 18 months after surgery.
Effect of implant orientation on success in pressure
measurement. In 17 patients, the implant was deployed
facing the aneurysm sac; in four patients the implant was
deployed between the limbs of the stent-graft (Fig 2). In
the first of the four patients with the device deployed
Shrinkage
No shrinkage 
 (mm)
mean pressure index (MPI) and the change in abdominal
meter (mm)
Shrinkage
No shrinkage
mean pressure index (MPI) and the change in abdominaleter
n the Dia
n thebetween the limbs, intraoperative pressures and pressures at
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however, this patient’s implant recorded pressures as “out
of range,” meaning that the implant was sensing pressures
250 mm Hg. Two additional patients with the implants
placed between the iliac limbs registered “out of range”
errors immediately after implantation. In the fourth pa-
tient, initial pressures of 197/129 were measured when the
simultaneous sac catheter pressure was 129/88. The im-
plant was reading “out of range” by the 6-month follow-up.
These four implants are presumably registering elevated
pressures because they are directly compressed between the
iliac limbs of the stent-graft. Two implants never func-
tioned, for unclear reasons.
Initial concordance. Intraoperative concordance be-
tween transducer-derived sac pressures and catheter-
derived sac pressures was excellent in those patients whose
implants were externally oriented. The Pearson correlation
coefficient for systolic, diastolic, and pulse pressures were
0.97, 0.97, and 0.96, respectively (P  .001).
Mean pressure index and sac diameter correlation.
Fourteen patients had at least 6 months of follow-up and
functioning, externally oriented implants. Seven patients
had stable aneurysms (no change in diameter5 mm), and
seven had shrinking aneurysms. Median follow-up was 12
months (range, 8 to 20 months) in the stable group and 15
months (range, 8 to 25 months) in the shrinking group.
Mean pressure index and endoleak. Three of the
seven patients with stable aneurysms were diagnosed with
endoleaks. One patient was noted to have a distal type I
endoleak onMRA at 1month. After correction with an iliac
cuff, the patient has a persistent type II endoleak from
patent lumbar artery. Although this patient’s sac pressure
has diminished dramatically, with an MPI of 0.34 at 14
months, the size of her aneurysm has not changed. One
patient has a persistent type II from a patent inferior mes-
enteric artery, and one patient had a lumbar endoleak
which thrombosed at 6 months. Both patients have ele-
Change in AAA
Fig 5. Scatterplot demonstrates the relationship betwee
aortic aneurysm (AAA) diameter at the last follow-up.vated sac pressures (MPI of 1.09 and 1.06, respectively).Of the seven patients with shrinking aneurysms, two
had type II endoleaks. One was visualized on the 1-month
CT and sealed spontaneously by the 6-month CT. The
MPI decreased from 0.72 to 0.031 over the same period,
with a 7-mm decrease in aortic diameter. One type II
persisted until the 12-month CT. Notably, at 6 months,
this patient had an MPI of 0.17 and the sac had shrunk by
7 mm, despite a patent endoleak.
Mean pressure index vs changes in sac diameter.
Median MPI was significantly less in the shrinkage group
than in the stable group at 6 months (P .017) and at the
final clinic follow-up (P .048). At 12months, the median
MPI was 0.53 in the stable group vs 0.24 in the shrinking
group; however, this was not statistically significant (P 
0.11) (Tables I to III, Figs 3 to 5). At 6 months, median
absolute sac pressure in the shrinkage group was 18/15
(range, 9 to 22/2 to 16); median absolute sac pressure in
the stable group was 82/63 (range, 31 to 156/24 to 119).
This difference was significant (systolic, P 0.01; diastolic,
P 0.01). At 12 months, the median absolute sac pressure
was 33/24 (range, 12 to 70/4 to 67) in the shrinking
group vs 69/49 (range, 28 to 115/18 to 96) in the stable
group; however, this was not significantly different (sys-
tolic, P  .13; diastolic, P  .15). At final follow-up, the
median absolute sac pressure was 34/17 (range, 13 to
68/1 to 64) in the shrinking group vs 72/54 (range, 28 to
114/16 to 95) in the stable group; however, this was not
significantly different (systolic, P .06; diastolic, P .08).
DISCUSSION
Multiple factors determine aneurysm sac pressure after
EVAR. Device-related factors include the presence of en-
doleak, graft porosity, and device compliance.8-14 Ana-
tomic factors include the patency of aneurysm side
branches, aneurysm morphology, and the character of an-
eurysm thrombus.10,14,15 Experimental models have
shown that with exclusion of the sac after EVAR, sac
Shrinkage     
No shrinkage
meter (mm)
mean pressure index (MPI) and the change in abdominal Dia
n thepressures can be expected to diminish significantly.8-11,14
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al,15 who performed direct translumbar puncture in pa-
tients after EVAR with sac shrinkage and no evidence of
endoleak. In these patients, mean intrasac pressure dimin-
ished to 20% of mean arterial pressure.
What happens in the presence of endoleak is less clear.
Baum et al16 reported that they found elevated pressures in
all patients being investigated for endoleak; however, these
patients were identified on their 1-month CT scans and
referred for angiography. In our experience, aneurysm sac
pressure diminished gradually over time, and all patients
had a sac systolic pressure greater than the systemic diastolic
pressure at 1 month.6 The presence or absence of endoleak
could not be predicted by sac pressure at one month.
The relationship between sac pressure and changes in
sac diameter over time is becoming clearer. In a follow-up
study to the work of Sonesson et al,15 Dias et al17 demon-
strated that shrinking aneurysms were associated with low
sac pressures and enlarging aneurysms were associated with
elevated sac pressures. This agrees with our findings. Addi-
tionally, they also found that sac pressures in patients with
type II endoleaks were varied and dynamic. Clearly, the
mechanism of sac shrinkage is multifactorial, as patients
with the same MPI shrank at different rates.
A potential limitation of this study is that with only one
transducer implanted per patient, the question of sac com-
partmentalization cannot be addressed. Also, reliable pres-
sure measurements could not be obtained in four patients
because the implants were compressed between the stent-
graft limbs; the deployment technique has since been mod-
ified. We are still investigating the cause of the failure of the
two other nonworking implants. Further clinical experi-
ence will be necessary to elucidate the relationship between
AAA sac pressure, endoleak, and sac shrinkage.
CONCLUSION
Long-term noninvasive sac pressure monitoring is fea-
sible. Sac pressures diminish over the course of several
months in most patients with complete aneurysm exclu-
sion. Even in the presence of some type II endoleaks, sac
pressures decrease significantly. Patients with aneurysm
shrinkage after EVAR have significantly lower sac pressures;
however, the absence of sac shrinkage does not imply persis-
tent pressurization of the sac. Further clinical follow-up will
delineate the role of chronic sac pressure monitoring in
surveillance after EVAR.8
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Dr Evan C. Lipsitz (Bronx, NY). I’d like to congrat- initial experience published last year. I have several ques-
tions:
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from the device been observed either in bench-top or
animal testing over time?
2. Many authors are concerned about issues that relate to
compartmentalization of the aneurysm sac. In other
words, pressure measurements may differ depending on
where they’re actually measured within the sac, for exam-
ple, within clot vs within an endoleak flow channel.Would
the authors comment on how pressure readings may vary
depending on the position of the sensor within the sac?
3. I counted five patients in this series who had a type II
endoleak at some point during the study. Three of them
had stable aneurysm size and in two patients the aneu-
rysm shrunk. Were the early sensor readings predictive
of these changes?
4. Finally, what costs or cost savings have been observed or
are anticipated with the use of this sensor? Exclusive of
the follow-up for the Talent graft, what follow-up pro-
tocol would you recommend for patients who have
sensors in place? What are the advantages of this system
as opposed to simply following sac size with duplex or
non-contrast CT scan and reserving contrast interven-
tions for patients who have enlarging aneurysms?
Dr Sharif H. Ellozy. With regard to the first question
of degradation of the precision of measurement, our study
is not designed to assess the accuracy of the sensors in
follow-up. But Dr RossMilner at Emery, along with Dr Jan
Blankenstein, has performed animal studies looking at this
in a pig model. They implanted sensors, and then explanted
them at about 2months. They found that there was no drift
of more than 5 mm Hg in pressure measurement.
With regards to the bench-top testing from the manu-
facturer, they report that there’s no drift over the course of
several months. With regards to compartmentalization,
probably the best way to address that would be to implant
multiple sensors in multiple locations. However, you are
limited by cost and feasibility. Most of the experimental
work looking at compartmentalization finds that pressures
are greatest closest to the device itself. So if we are going to
implant one device, attaching it to the device would be a
good place to measure the highest pressure in the sac,
which is really what you are most concerned about.
With regards to our type II endoleaks, it seems that
they are a mixed bag. Some of them have elevated pres-
sures, some of them have diminished pressures. As far as
predicting who is going to develop an endoleak, what was
interesting was that at 1-month, almost everybody had
similar pressures. The sac systolic was higher than systemic
diastolic in all patients. And the diastolic was usually slightly
lower than the systemic diastolic, but about the same. So it
seems that pressures evolved over the course of several
months, and there is no way to predict the presence of
endoleaks on the basis of their 1-month pressure.
It’s still premature to say anything with regards to
surveillance and sac pressure measurement. We’re just find-
ing out what happens to the aneurysm sac pressure over
time. Presently, we have extensive experience with fol-low-up with regards to endoleak and sac size changes, so I
wouldn’t change my surveillance protocol based on that.
Dr Alan Dardik (New Haven, Conn). I have two
questions:
1. Have you been able to look at the presence of thrombus?
And does that make any difference to the measurements?
2. Can you tell us what the patients think about this device?
Does this reassure them or does it nowmake themmore
nervous that something is going to happen and their
pressure measurements are about to go up?
Dr Ellozy. Those are two very good questions. One of
the things we are investigating (which I didn’t present
today) is MR characterization of aneurysm sac thrombus.
There is a sequence that is used in cardiac MR that can
differentiate well between myocardium and blood. It seems
that in some of our patients with endotension, with no
demonstrable endoleak, when we perform this sequence,
the thrombus is almost entirely liquid. There’s a very large
liquid component in the sac. However, in patients whose
sacs are shrinking, the thrombus looks organized on this
sequence. It seems that those patients who have extensive
liquid component have higher pressures in the sac.
Now, these finds are still preliminary enough thatwe can’t
say anything definitive. But I think that the character of the sac
content is crucial in the transmission of pressure to the wall.
And we know this from animal studies. We know that orga-
nized thrombus doesn’t transmit pressure nearly as well as
whole blood or unclotted blood, which makes sense.
We reassure all our patients, especially the patients in
whom we can’t get good measurements, that the sac pres-
sure measurement doesn’t change anything as far as their
follow-up goes. As mentioned before, our understanding
of the importance of sac pressure is still very preliminary.
Dr Anil Hingorani (Brooklyn, NY). How much does
it cost?
Dr Ellozy. I don’t know howmuch it is going to cost,
how much it is going to ultimately translate to the patient,
because the company gives it to us for free at this point.
Dr Hingorani. And the type I endoleak that you had,
was that postoperative?
Dr Ellozy. Presumably, it was there since the begin-
ning, but it was diagnosed on the 1-month CT scan. It was
a distal type I endoleak.
Dr Hingorani. And what was the pressure index at
that point in time when the type I was still open?
Dr Ellozy. The pressure at that time, the systemic
pressure, was about 150/80, and the pressure in the en-
doleak was something like 145/90. The systolic was slightly
lower and the diastolic was slightly higher. Interestingly
enough, we brought her back for an angio to confirm this.
And when we wedged the catheter distally into the endoleak
channel and compared it to the pressure measured by the
sensor, which was about 6 cm away, they correlated exactly.
But like I said, almost everybody has elevated pressures in the
first month, so elevated pressures are not really predictive of
the presence or absence of endoleak.
